Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 179Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ANDA Repository

02 1ANGITA PHARMA INC.

03 5Actavis Inc

04 2Adcock Ingram

05 2AiPing Pharmaceutical Inc

06 3Apotex Inc

07 2Aspire Lifesciences Pvt Ltd

08 1Auro Pharma Inc

09 4Aurobindo Pharma Limited

10 3Chartwell Pharmaceuticals llc

11 2Eurofarma Laboratorios S.A

12 3Graviti Pharmaceuticals

13 1Grupo Azevedos

14 2InvaGen Pharmaceuticals Inc

15 3Inventia Healthcare Limited

16 1JAMP PHARMA

17 2Johnson & Johnson Innovative Medicine

18 3Jubilant Cadista Pharmaceuticals

19 2KVK.Tech

20 1LABORATOIRE RIVA INC.

21 2Macleods Pharmaceuticals Limited

22 2Novast Laboratories

23 2Oxford Pharm

24 1PRO DOC LIMITEE

25 2Par Pharmaceutical

26 2Pharmascience Inc.

27 1Pliva Hrvatska

28 2Prinston

29 3Rising Pharmaceuticals Inc

30 3Rubicon Research

31 1SANIS HEALTH INC

32 1SIT LABORATORIO FARMAC. Srl

33 1SIVEM PHARMACEUTICALS ULC

34 1Sandoz B2B

35 2Sudarshan Pharma

36 3Sun Pharmaceutical Industries Limited

37 2TWi Pharmaceuticals

38 3Teva Pharmaceutical Industries

39 3Unichem Pharmaceuticals USA, Inc

40 6Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1989-05-03

Application Number : 71611

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2006-02-03

Application Number : 71611

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 7.5MG

Packaging :

Approval Date : 2006-02-03

Application Number : 71611

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1991-11-27

Application Number : 73143

Regulatory Info : DISCN

Registration Country : USA

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1994-11-30

Application Number : 74436

Regulatory Info : DISCN

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1991-11-19

Application Number : 72854

Regulatory Info : DISCN

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2006-02-03

Application Number : 72854

Regulatory Info : DISCN

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1995-05-23

Application Number : 73541

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2006-04-06

Application Number : 73541

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : FLEXERIL

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-01-01

Application Number : 17821

Regulatory Info : DISCN

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : FLEXERIL

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-01-01

Application Number : 17821

Regulatory Info : DISCN

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2005-10-04

Application Number : 77209

Regulatory Info : RX

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2006-02-03

Application Number : 77209

Regulatory Info : RX

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1995-09-29

Application Number : 74421

Regulatory Info : DISCN

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1991-05-30

Application Number : 73144

Regulatory Info : DISCN

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 5MG

Packaging :

Approval Date : 2006-02-03

Application Number : 73144

Regulatory Info : DISCN

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 7.5MG

Packaging :

Approval Date : 2013-03-25

Application Number : 73144

Regulatory Info : DISCN

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : CYCLOBENZAPRINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 1993-02-26

Application Number : 73683

Regulatory Info : DISCN

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : AMRIX

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 15MG

Packaging :

Approval Date : 2007-02-01

Application Number : 21777

Regulatory Info : RX

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CYCLOBENZAPRINE HYDROCHLORIDE

Brand Name : AMRIX

Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL

Dosage Strength : 30MG

Packaging :

Approval Date : 2007-02-01

Application Number : 21777

Regulatory Info : RX

Registration Country : USA

blank